aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. (2020)
Attributed to:
Immunity in the face of diversity and the development of novel potent HCV vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2020.07.025
PubMed Identifier: 32707225
Publication URI: http://europepmc.org/abstract/MED/32707225
Type: Journal Article/Review
Volume: 73
Parent Publication: Journal of hepatology
Issue: 6
ISSN: 0168-8278